Precision cancer medicine in Europe: a mixed-methods study on infrastructure for extended molecular diagnostics.

Henkel PS, Pedersen K, Taskén K, Hult EH, Gelderblom H, Fagereng GL, Landsverk HB, Aas E, PCM4EU consortium partners.

Open source

DOI
10.1007/s00432-026-06468-y
Published
2026-04-02
Container
J Cancer Res Clin Oncol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00432-026-06468-y,
  title = {Precision cancer medicine in Europe: a mixed-methods study on infrastructure for extended molecular diagnostics.},
  author = {Henkel PS and  Pedersen K and  Taskén K and  Hult EH and  Gelderblom H and  Fagereng GL and  Landsverk HB and  Aas E and  PCM4EU consortium partners.},
  year = {2026},
  journal = {J Cancer Res Clin Oncol},
  doi = {10.1007/s00432-026-06468-y},
  url = {https://doi.org/10.1007/s00432-026-06468-y}
}

RIS

TY  - JOUR
TI  - Precision cancer medicine in Europe: a mixed-methods study on infrastructure for extended molecular diagnostics.
AU  - Henkel PS
AU  -  Pedersen K
AU  -  Taskén K
AU  -  Hult EH
AU  -  Gelderblom H
AU  -  Fagereng GL
AU  -  Landsverk HB
AU  -  Aas E
AU  -  PCM4EU consortium partners.
PY  - 2026
JO  - J Cancer Res Clin Oncol
DO  - 10.1007/s00432-026-06468-y
UR  - https://doi.org/10.1007/s00432-026-06468-y
ER  - 

APA

PS, H., K, P., K, T., EH, H., H, G., GL, F., HB, L., E, A., & partners., P. C. (2026). Precision cancer medicine in Europe: a mixed-methods study on infrastructure for extended molecular diagnostics.. J Cancer Res Clin Oncol. https://doi.org/10.1007/s00432-026-06468-y

Source records